Eckert & Ziegler SE Share Price Berne S.E.

Equities

EUZ

DE0005659700

Office Equipment

Delayed Berne S.E. 10:30:01 18/03/2024 pm IST 5-day change 1st Jan Change
36.37 CHF -2.79% Intraday chart for Eckert & Ziegler SE -.--% +3.34%

Financials

Sales 2024 * 271M 290M 258M 24.23B Sales 2025 * 296M 317M 283M 26.5B Capitalization 955M 1.02B 910M 85.33B
Net income 2024 * 34M 36.38M 32.4M 3.04B Net income 2025 * 36M 38.52M 34.3M 3.22B EV / Sales 2024 * 3.36 x
Net cash position 2024 * 43.4M 46.44M 41.36M 3.88B Net cash position 2025 * 42.6M 45.58M 40.59M 3.81B EV / Sales 2025 * 3.08 x
P/E ratio 2024 *
27.6 x
P/E ratio 2025 *
25.9 x
Employees -
Yield 2024 *
1.09%
Yield 2025 *
1.09%
Free-Float 67.11%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 57 01/17/01
Founder 55 01/97/01
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 71 01/19/01
Founder 55 01/97/01
Director/Board Member 71 29/19/29
More insiders
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
45.8 EUR
Average target price
62.5 EUR
Spread / Average Target
+36.46%
Consensus

Annual profits - Rate of surprise